Modified myelin basic protein molecules

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S377000, C435S007240, C435S975000, C530S300000, C530S324000, C530S350000

Reexamination Certificate

active

07041503

ABSTRACT:
Compositions and methods are provided for the clinical assessment, diagnosis, and treatment of multiple sclerosis. The compositions of the invention are molecules related to the 21.5 kDa fetal isoform of human myelin basic protein, and include nucleic acids and polypeptides. The nucleic acid molecules of the invention are useful in the efficient production of modified and unmodified 21.5 kDa myelin basic protein polypeptides, such polypeptides being useful for assaying T cells for responsiveness to myelin basic protein epitopes. The polypeptides of the invention are also useful as therapeutic agents that act by inducing T cell responses, including apoptosis, as a means of treating multiple sclerosis.

REFERENCES:
patent: 4853332 (1989-08-01), Mark et al.
patent: 5871997 (1999-02-01), Rother et al.
patent: 5935575 (1999-08-01), Lenardo et al.
patent: 5989546 (1999-11-01), Lenardo
patent: 6039947 (2000-03-01), Weiner et al.
patent: 6083503 (2000-07-01), Lenardo
patent: 6083504 (2000-07-01), Cotropia
patent: WO 94/03202 (1994-02-01), None
patent: WO 94/28926 (1994-12-01), None
patent: WO 96/34622 (1996-11-01), None
Voskhul et al, J. Immunology, 153(10):4834-4844, 1994.
Voskhul et al, J. Neuroimmurdl 46(1-2):137-144, 1993.
Kamholz et al, Proc. Natl. Acad-Sci USA, 83: 4962-4966, 1987.
Pareyra et al., Nerochemical Research 13(6): 583-595, 1988.
Raines et al, Handbook of Clinical Neurology 3(47): 429-466, 1985),
Alvord et al, Annals Neurology, 6(6): 461-468, 1978.
Traugott et al, J. Neurosciences, 56: 65-73, 1982).
Weiner et al, Science 259: 1263, 1993.
Bielokova et al (Nature Medicine 6(10): 1167-1175, Oct. 2000).
Popot et. al. Major Myelin Proteolipid: The 4-Alpha Helix Toplogy J. Membrane Biol. 120, 223-246 (1991).
Weimbs et al. A Point Mutation at the X-Chromosomal Proteolipid Protein Locus in Pelzaeus- Merzbacher Disease Leads to Disruption of Myelinogenesis Biol. Chem. Hoppe-Seyler. vol. 371, pp. 1175-1183, Dec. 1990.
Hudson L D et al: Mutation of the Proteolipid Protein Gene PLP in a human X Chromosome- Linked Myelin Disorder Proc. Natl. Acad. Sci. USA. vol. 86, pp. 8128-8131, No. 20 Oct. 1989.
Simons R et al: Single Base Substitution in Condon 74 of the MD Rat Myelin Proteolipid Protein Gene. Annals of the New York Academy of Sciences, New Yo NY. U.S., vol. 605, 1990. pp. 146-154.
Simons R et al: The Myelin- Deficient Rat has a Single Base Substitution in the Third exon of the Myelin Proteolipid Protein Gene Journal of Neurochemistry, New York N.Y. US, vol. 54, No. 3, Mar. 1990 pp. 1079-1081.
Tsuchida T. et al: Autoreactive CD8+T−Cell Responses to Human Myelin Protein Derived Peptides. Proceeding of the National Academy of Science U.S.A. Washington, US. vol. 91, No. 23, Nov. 1994 pp. 10859-10863.
Nye et al. Purification of Immunologically Active Recombinant 21.5 kDa Isofor of Human Myelin Basic Protein. Molecular Immunology, vol. 32, No. 14/15 pp. 1131-1141.
Zhao et al. The immune response to a subdominant epitode in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes. Journal of Neuroimmunology 61 pp. 179-184 (1995).
Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkey. Meinl et al. International Immunology, vol. 7, No. 9, pp. 1489-1495.
Identification of a cDNA coding for a fifth form of myelin basic protein in mouse. Newman et al. Proc. Natl. Acad. Sci. USA vol. 84, pp. 886-890, Feb. 1987 Neurobiology.
Evidence for the Expression of Four Myelin Basic Protein Variants in the Developing Human Spinal Cord Through cDNA Cloning. Roth et al. Journal of Neuroscience Research 17:321-328 (1987).
Identification of three forms of human myelin basic protein by cDNA cloning. Kamholz et al. Proc. Natl. Acad. Sci. USA vol. 83, pp. 4962-4966, Jul. 1986 Neurobiology.
H.L. Weiner et al.: Double-Blind Pilot Trial of Oral tolerization with Myeli Antigens in Multiple sclerosis Science, vol. 259, Feb. 26, 1993 pp. 1321-1324.
Abbas et al.,Cell. Mol. Immunology 2ndEd., Ch. 19, 377-392 (1994).
Adorini et al.,Immunol. Today, 14(6), 285-289, (1993).
Alderson et al.,J. Exp. Med., 181, 71-77 (1995).
Allegretta et al.,Science, 247, 718-721 (1990).
Boehme et al.,Eur. J. Immunol., 23, 1552-1560 (1993).
Bolton,Mult. Scier., 1, 143-149 (1995).
Brown et al.,Lab. Invest., 45(3), 278-284 (1981).
Brück et al.,Ann. Neurol., 35, 65-73 (1994).
Burns et al.,J. Exp. Med., 169, 27-39 (1989).
Chou et al.,J. Neuroimmunol., 38, 105-114 (1992).
Chou et al.,J. Neurosci. Res., 23, 207-216 (1989).
Cohen et al.,Annu. Rev. Immunol., 10, 267-293 (1992).
Cotter et al.,Anticancer Res., 10, 1153-1160 (1990).
CRISPE,Immunity, 1, 347-349 (1994).
Critchfield et al.,Science, 263, 1139-1143 (1994).
Deibler et al.,Prep. Biochem., 2(2), 139-165 (1972).
Diehl et al,Proc. Natl. Acad. Sci. USA, 83, 9807-9811 (1986).
Duvall et al.,Immunol. Today, 7(4), 115-119 (1986).
Einstein et al.,J. Neurochem., 9, 353-361 (1962).
Elliott et a.,J. Clin. Invest., 98(7), 1602-1612 (1996).
Endoh et al.,J. Immunol., 137(12), 3832-3835 (1986).
Evans et al.,Gene, 84, 135-142 (1989).
Fritz et al.,J. Immunol., 130(1), 191-194 (1983).
Fritz et al.,J. Neuroimmunol., 51, 1-6 (1994).
Greer et al.,J. Immunol., 149(3), 783-788 (1992).
Grosjean et al.,Gene, 18, 199-209 (1982).
HAUSER,Harrison's Principles of Int. Med. 13thEd., Ch. 373, 2287-2295 (1994).
Hernan et al.,Biochem., 31(36), 8619-8628 (1992).
Ho et al.,Gene, 77, 51-59 (1989).
Huang et al.,Mol. Cell. Biol., 10(4), 1805-1810 (1990).
Jayaraman et al.,Proc. Natl. Acad. Sci. USA, 88, 4084-4088 (1991).
Kalghatgi et al.,J. Chromatogr., 398, 335-339 (1987).
Kamholz et al.,J. Neurosci. Res., 21, 62-70 (1988).
Kaufman et al.,Nature, 366, 69-72 (1993).
Kawabe et al.,Nature, 349, 245-248 (1991).
Kennedy et al.,J. Immunol., 144(3), 909-915 (1990).
Kerlero De Rosbo et al.,J. Clin. Invest., 92, 2602-2608 (1993).
Kerr et al.,Apoptosis: The Molecular Basis of Cell Death, 5-29 (1991).
Kronquist et al.,J. Neurosci. Res., 18, 395-401 (1987).
Kuchroo et al.,J. Immunol., 148(12), 3776-3782 (1992).
Kuchroo et al.,J. Immunol., 153, 3326-3336 (1994).
Lees et al.,Neuronal and Glial Proteins, Ch. 11, 267-298 (1988).
Lehmann et al.,Nature, 358, 155-157 (1992).
LENARDO,Nature, 353, 858-861 (1991).
Linthicum et al.,Cell. Immunol., 73, 299-310 (1982).
Lockshin et al,Apoptosis: The Molecular Basis of Cell Death, 47-60 (1991).
Marrack et al.,Science, 238, 1073-1078 (1987).
Martin et al.,Annu. Rev. Immunol., 10, 153-187 (1992).
Martin et al.,J. Immunol., 145(2), 540-548 (1990).
Massacesi et al.,Ann. Neurol., 37(4), 519-530 (1995).
Matis et al.,Proc. Natl. Acad. Sci., USA, 80, 6019-6023 (1983).
McCarron et al.,J. Neuroimmunol., 29, 73-79 (1990).
McFarland et al.,J. Immunol., 166, 2116-2121 (2001).
McRae et al.,J. Neuroimmunol., 38, 229-240 (1992).
Meinl et al.,J. Clin. Invest., 92, 2633-2643 (1993).
Miller et al.,Immunol. Today, 15(8), 356-361 (1994).
Miller et al.,J. Neuroimmunol., 39, 243-250 (1992).
MITCHISON,Proc. R. Soc. London Ser. B, 161, 275-292 (1964).
Morgenstern et al.,Nucl. Acids Res., 18(12), 3587-3596 (1990).
Oettinger et al.,J. Neuroimmunol., 44, 157-162 (1993).
Ota et al.,Nature, 346, 183-187 (1990).
Pelfrey et al.,J. Neuroimmunol., 46, 33-42 (1993).
Pelfrey et al.,J. Neuroimmunol., 53, 153-161 (1994).
Pette et al.,Neurology, 40, 1770-1776 (1990).
Prineas et al.,Ann. Neurol., 33, 137-151 (1993).
Raine et al.,J. Neuropathol. Exp. Neurol., 52(3), 199-204 (1993).
Ransohoff et al.,Curr. Opin. Neurol., 7, 242-249 (1994).
Richert et al.,J. Neuroimmunol., 23, 55-66 (1989).
Russell et al.,Proc. Natl. Acad. Sci., USA, 90, 4409-4413 (1993).
Saeki et al.,Proc. Natl. Acad. Sci., USA, 89, 6157-6161 (1992).
Sakai et al.,Proc. Natl. Acad. Sci., USA, 86, 9470-9474 (1989).
Sato et al.,J. Biol. Chem., 269(25), 17267-17273 (1994).
Schwartz et al.,Fundamental Immunology, 3rdEd., Ch. 30, 1033-1097 (1993).
Segal et al.,J. Neuromimmunol., 51, 7-19 (1994).
Sercarz et al.,Nature, 184, 1080-1082 (1959).
Singer et al.,Immunity, 1, 365-371 (1994).
Smith et al.,Nature, 337, 181-184 (1989).
Sobel et al.,J. Immunol., 149(4), 1444-1451 (1992).
S

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified myelin basic protein molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified myelin basic protein molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified myelin basic protein molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3524972

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.